Control of the Cell Cycle

Published on 04/03/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1132 times

Chapter 4

Control of the Cell Cycle

Summary of Key Points

• Most cells in postnatal tissues are quiescent. Exceptions include abundant cells of the hematopoietic system, skin, and gastrointestinal mucosa, as well as other minor progenitor populations in other tissues.

• Many quiescent cells can reenter into the cell cycle with the appropriate stimuli, and the control of this process is essential for tissue homeostasis.

• The key challenges for proliferating cells are to make an accurate copy of the 3 billion bases of DNA (S phase) and to segregate the duplicated chromosomes equally into daughter cells (mitosis).

• Progression through the cell cycle is dependent on both intrinsic and extrinsic factors, such as growth factor or cytokine exposure, cell-to-cell contact, and basement membrane attachments.

• The internal cell cycle machinery is controlled largely by oscillating levels of cyclin proteins and by modulation of cyclin-dependent kinase (Cdk) activity. One way in which growth factors regulate cell cycle progression is by affecting the levels of the D-type cyclins, Cdk activity, and the function of the retinoblastoma protein.

• Cell cycle checkpoints are surveillance mechanisms that link the rate of cell cycle transitions to the timely and accurate completion of prior dependent events. p53 is a checkpoint protein that induces cell cycle arrest, senescence, or death in response to cellular stress.

• Checkpoints minimize replication and segregation of damaged DNA or the abnormal segregation of chromosomes to daughter cells, thus protecting cells against genome instability.

• Disruption of cell cycle controls is a hallmark of all malignant cells. Frequent tumor-associated alterations include aberrations in growth factor signaling pathways, dysregulation of the core cell cycle machinery, and/or disruption of cell cycle checkpoint controls.

• Because cell cycle control is disrupted in virtually all tumor types, the cell cycle machinery provides multiple therapeutic opportunities.

Self-Assessment Questions

1. Which statement best describes the function of the retinoblastoma protein?

(See Answer 1)

2. Checkpoint abrogation is a therapeutic strategy based on the inhibition of checkpoint proteins. What is the major difference between inhibiting basic cell cycle regulators versus inhibiting checkpoint regulators for cancer therapy?

(See Answer 2)

3. Most cancers are aneuploid or present chromosomal instability (CIN). What are the consequences of having a high rate of chromosome gains and losses for tumor development?

(See Answer 3)